Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DL-3-n-butylphthalide in acute large area cerebral infarction (observational)
ChiCTR2100046518Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of butylphthalide in brain infarction (2 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoint: Modified Rankin Scale at 90 days. Started Jan 2016; status: completed.
02
Drugs
butylphthalide
03
Conditions
brain infarction
Beyond the preview
Go deeper on ChiCTR2100046518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046518.